BIOR has 36-month beta value of 1.23. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for BIOR is 4.37M, and currently, short sellers hold a 4.62% ratio of that float. The average trading volume of BIOR on November 19, 2024 was 55.89K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
BIOR) stock’s latest price update
Biora Therapeutics Inc (NASDAQ: BIOR)’s stock price has plunge by -14.62relation to previous closing price of 2.12. Nevertheless, the company has seen a -33.46% plunge in its stock price over the last five trading sessions. globenewswire.com reported 2024-11-14 that Testing in advanced animal model planned in Q4 f or smaller, 00-size BioJet device with largest capacity of any ingestible injectable
BIOR’s Market Performance
Biora Therapeutics Inc (BIOR) has experienced a -33.46% fall in stock performance for the past week, with a -57.91% drop in the past month, and a -74.17% drop in the past quarter. The volatility ratio for the week is 17.35%, and the volatility levels for the past 30 days are at 14.21% for BIOR. The simple moving average for the last 20 days is -41.50% for BIOR stock, with a simple moving average of -74.00% for the last 200 days.
BIOR Trading at -60.99% from the 50-Day Moving Average
After a stumble in the market that brought BIOR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -90.90% of loss for the given period.
Volatility was left at 14.21%, however, over the last 30 days, the volatility rate increased by 17.35%, as shares sank -60.13% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -72.15% lower at present.
During the last 5 trading sessions, BIOR fell by -33.46%, which changed the moving average for the period of 200-days by -80.73% in comparison to the 20-day moving average, which settled at $3.09. In addition, Biora Therapeutics Inc saw -86.59% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for BIOR
Current profitability levels for the company are sitting at:
- -34.51 for the present operating margin
- 0.81 for the gross margin
The net margin for Biora Therapeutics Inc stands at -17.88. The total capital return value is set at 0.57.
Based on Biora Therapeutics Inc (BIOR), the company’s capital structure generated -0.57 points at debt to capital in total, while cash flow to debt ratio is standing at -0.14. The debt to equity ratio resting at -0.36. The interest coverage ratio of the stock is -18.49.
Currently, EBITDA for the company is -114.05 million with net debt to EBITDA at -1.47. When we switch over and look at the enterprise to sales, we see a ratio of 24.71. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.05.
Conclusion
To put it simply, Biora Therapeutics Inc (BIOR) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
